Alternative Medicine

Congratulations on the publication of the Commentary by Dimitri Viza (The Scientist, 12[18]:8, Sept. 14, 1998). His comments are pertinent and powerful. However, I believe that he fails to give sufficient emphasis to why research is performed in the first place. Surely there must be some individuals who are driven by a need to answer a question that they believe is of overwhelming significance, such as, "How can the ability of organisms to learn be improved?" or "What is the basis of altruist

Written byGeorge Spaeth
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Congratulations on the publication of the Commentary by Dimitri Viza (The Scientist, 12[18]:8, Sept. 14, 1998). His comments are pertinent and powerful. However, I believe that he fails to give sufficient emphasis to why research is performed in the first place. Surely there must be some individuals who are driven by a need to answer a question that they believe is of overwhelming significance, such as, "How can the ability of organisms to learn be improved?" or "What is the basis of altruistic behavior?" But, by and large, subjects are selected to be studied because funds are available for that project, and, as the old saying goes, he who pays the piper calls the tune. Until there is a fundamental change in the way research is supported, the important questions raised by Dr. Viza will not be addressed. The change, of course, is supporting the investigators, not the projects, so ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies